Soleno Therapeutics (SLNO) Competitors $70.25 +0.25 (+0.36%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$70.00 -0.25 (-0.36%) As of 04/15/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SLNO vs. SOLV, SNN, PEN, STVN, GKOS, NARI, INSP, BLCO, IRTC, and PRCTShould you be buying Soleno Therapeutics stock or one of its competitors? The main competitors of Soleno Therapeutics include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry. Soleno Therapeutics vs. Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb iRhythm Technologies PROCEPT BioRobotics Soleno Therapeutics (NASDAQ:SLNO) and Solventum (NYSE:SOLV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do insiders and institutionals hold more shares of SLNO or SOLV? 97.4% of Soleno Therapeutics shares are owned by institutional investors. 12.3% of Soleno Therapeutics shares are owned by company insiders. Comparatively, 0.1% of Solventum shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend SLNO or SOLV? Soleno Therapeutics presently has a consensus target price of $99.63, suggesting a potential upside of 41.81%. Solventum has a consensus target price of $79.86, suggesting a potential upside of 21.04%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Soleno Therapeutics is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor SLNO or SOLV? Soleno Therapeutics received 319 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 72.56% of users gave Soleno Therapeutics an outperform vote while only 4.17% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSoleno TherapeuticsOutperform Votes32072.56% Underperform Votes12127.44% SolventumOutperform Votes14.17%Underperform Votes2395.83% Which has higher valuation and earnings, SLNO or SOLV? Solventum has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoleno TherapeuticsN/AN/A-$38.99M-$4.26-16.49Solventum$8.25B1.38$475.76M$2.7523.99 Does the media favor SLNO or SOLV? In the previous week, Soleno Therapeutics and Soleno Therapeutics both had 13 articles in the media. Solventum's average media sentiment score of 1.36 beat Soleno Therapeutics' score of 1.26 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Soleno Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SLNO or SOLV more profitable? Solventum's return on equity of 0.00% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Soleno TherapeuticsN/A -61.99% -55.21% Solventum N/A N/A N/A SummarySoleno Therapeutics beats Solventum on 8 of the 15 factors compared between the two stocks. Remove Ads Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLNO vs. The Competition Export to ExcelMetricSoleno TherapeuticsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.22B$3.09B$5.33B$7.57BDividend YieldN/A1.81%5.11%4.33%P/E Ratio-21.1614.3421.7317.81Price / SalesN/A43.73379.1494.58Price / CashN/A44.0938.1534.64Price / Book13.613.336.464.00Net Income-$38.99M$94.03M$3.20B$247.23M7 Day Performance18.99%5.33%6.54%7.26%1 Month Performance42.38%-8.47%-8.55%-6.26%1 Year Performance82.37%-22.20%10.33%-0.18% Soleno Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLNOSoleno Therapeutics4.7804 of 5 stars$70.25+0.4%$99.63+41.8%+82.4%$3.22BN/A-21.1630Analyst ForecastGap DownSOLVSolventum1.6862 of 5 stars$65.25-1.4%$79.86+22.4%+6.9%$11.29B$8.25B23.7322,000Positive NewsHigh Trading VolumeSNNSmith & Nephew2.6469 of 5 stars$25.71-2.3%$27.00+5.0%+9.2%$11.24B$5.81B11.9020,100News CoveragePositive NewsGap DownHigh Trading VolumePENPenumbra3.8585 of 5 stars$263.59+0.5%$294.47+11.7%+29.5%$10.15B$1.19B775.253,900Upcoming EarningsAnalyst ForecastShort Interest ↑STVNStevanato Group1.7406 of 5 stars€19.23+1.1%N/A-23.5%$5.82B$1.10B40.914,650Positive NewsGap DownGKOSGlaukos4.5608 of 5 stars$85.87+2.7%$163.25+90.1%-2.4%$4.86B$383.48M-29.92780Analyst ForecastHigh Trading VolumeNARIInari Medical0.3536 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6381 of 5 stars$149.72+5.5%$226.70+51.4%-34.3%$4.46B$802.80M86.541,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8719 of 5 stars$11.86-2.1%$18.82+58.7%-16.5%$4.18B$4.79B-13.0312,500Gap DownIRTCiRhythm Technologies0.9177 of 5 stars$100.17-0.2%$119.73+19.5%-8.0%$3.15B$591.84M-27.521,790Positive NewsPRCTPROCEPT BioRobotics2.3993 of 5 stars$50.83-0.8%$94.29+85.5%+4.6%$2.79B$224.50M-26.07430Positive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives Inspire Medical Systems Alternatives Bausch + Lomb Alternatives iRhythm Technologies Alternatives PROCEPT BioRobotics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLNO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLNO Stock Free SLNO Stock Alerts